Ursprung des Netzwerks ersten Grades von Michael Levin
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Unravel Biosciences, Inc.
Unravel Biosciences, Inc. BiotechnologyHealth Technology Unravel Biosciences is a rapid prototyping therapeutics company that uses AI biological network analysis and existing drugs to discover and clinically derisk entirely novel therapeutics and biomarkers for complex diseases. Unravel Biosciences is based in Boston, MA and was founded by Richard Novak, Frederic Vigneault, Michael Levin, and Donald Ingber. The company leverages its proprietary Bionav™ platform to combine target and drug discovery, preclinical screening, and patient stratification. Richard Novak has been the CEO since incorporation.
3
| Holding Company | Biotechnology | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Michael Levin
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Yale University | College/University | Doctorate Degree | |
Emulate, Inc.
Emulate, Inc. Drugstore ChainsRetail Trade Emulate, Inc. owns and operates Organs-on-Chips platform which acts as an automated human bioemulation platform for mimicking true human physiology. The firm's product responses to medicines, chemicals, and diseases can be predicted. The company was founded by James Coon, Donald Ingber and Geraldine Hamilton in July 2014 and is headquartered in Cambridge, MA. | Drugstore Chains | Founder | |
BOA Biomedical, Inc.
BOA Biomedical, Inc. Medical SpecialtiesHealth Technology BOA Biomedical, Inc. is a Miraki innovation company that focuses on infectious disease. The private company is based in Cambridge, MA. The company's mission is to provide innovative tools to fight the world's most deadly infectious diseases and their outcomes, including sepsis, hospital-acquired infections, antibiotic resistance, pandemic infections, pathogenic outbreaks, and the threat of bioterrorism. BOA Biomedical has an exclusive license to technology from the Wyss Institute. The company's platform manages infectious disease throughout the patient journey from diagnosis to tracking to treatment. The company was founded by Christopher J. P. Velis. | Medical Specialties | Director/Board Member | |
Rhinostics, Inc.
Rhinostics, Inc. Miscellaneous Commercial ServicesCommercial Services Rhinostics, Inc. is a company that revolutionizes swab-based sample processing workflows worldwide. The company is based in Brookline, MA. The company offers simple and elegant swab solutions that bring efficiencies and cost savings to laboratory workflows. The company's flagship product, the Rhinostic automated nasal swab, is designed to work in an automated workflow and offers a robust and consistent 10x sample throughput increase compared to manual methods. Rhinostics products are registered as class I exempt medical devices with the FDA and may be used for clinical collection upon CLIA validation. The company was founded by Michael Springer and Richard Novak. The CEO is Cheri L. Walker. | Miscellaneous Commercial Services | Founder |
Statistik
International
Vereinigte Staaten | 5 |
Sektoral
Consumer Services | 2 |
Retail Trade | 2 |
Health Technology | 2 |
Commercial Services | 2 |
Operativ
Director/Board Member | 6 |
Founder | 5 |
Doctorate Degree | 1 |
Graduate Degree | 1 |
Undergraduate Degree | 1 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Donald Ingber | 4 |
Richard Novak | 2 |
Frederic Vigneault | 1 |
- Börse
- Insiders
- Michael Levin
- Unternehmensverbindungen